메뉴 건너뛰기
The Lancet
Volumn 379, Issue 9821, 2012, Pages 1078-1080
What (if anything) to do about low-risk prostate cancer
Author keywords

[No Author keywords available]
Indexed keywords

DUTASTERIDE; PLACEBO; PROSTATE SPECIFIC ANTIGEN;
EID: 84859106640     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60066-X     Document Type: Note
Times cited : (5)
References (8)
  • 2
    • 0742323730 scopus 로고    scopus 로고
    • Active surveillance: Towards a new paradigm for the treatment of early prostate cancer
    • CC Parker Active surveillance: towards a new paradigm for the treatment of early prostate cancer Lancet Oncol 5 2004 101 106
    • (2004) Lancet Oncol , vol.5 , pp. 101-106
    • Parker, C.C.1
  • 3
    • 84859108456 scopus 로고    scopus 로고
    • Dutasteride in localised prostate cancer management: The REDEEM randomised, double-blind, placebo-controlled trial
    • 10.1016/S0140-6736(11)61619-X published online January 25.
    • NE Fleshner, MS Lucia, B Egerdie et al. Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial Lancet 2012 10.1016/S0140-6736(11)61619-X published online January 25.
    • (2012) Lancet
    • Fleshner, N.E.1    Lucia, M.S.2    Egerdie, B.3
  • 4
    • 77950498003 scopus 로고    scopus 로고
    • Effect of dutasteride on the risk of prostate cancer
    • GL Andriole, DG Bostwick, OW Brawley et al. Effect of dutasteride on the risk of prostate cancer N Eng J Med 362 2010 1192 1202
    • (2010) N Eng J Med , vol.362 , pp. 1192-1202
    • Andriole, G.L.1    Bostwick, D.G.2    Brawley, O.W.3
  • 5
    • 79960210525 scopus 로고    scopus 로고
    • The risks and benefits of 5 alpha-reductase inhibitors for prostate cancer prevention
    • MR Theoret, YM Ning, JJ Zhang et al. The risks and benefits of 5 alpha-reductase inhibitors for prostate cancer prevention N Engl J Med 365 2011 97 99
    • (2011) N Engl J Med , vol.365 , pp. 97-99
    • Theoret, M.R.1    Ning, Y.M.2    Zhang, J.J.3
  • 6
    • 80155181951 scopus 로고    scopus 로고
    • The VA/NCI/AHRQ CSP 407: Prostate cancer intervention versus observation trial (PIVOT): Main results from a randomized trial comparing radical prostatectomy to watchful waiting in men with clinically localized prostate cancer
    • Washington, DC, USA; May 14-19
    • Wilt TJ. The VA/NCI/AHRQ CSP 407: prostate cancer intervention versus observation trial (PIVOT): main results from a randomized trial comparing radical prostatectomy to watchful waiting in men with clinically localized prostate cancer. American Urological Association Annual Meeting; Washington, DC, USA; May 14-19, 2011.
    • (2011) American Urological Association Annual Meeting
    • Wilt, T.J.1
  • 7
    • 70449525320 scopus 로고    scopus 로고
    • A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer
    • MJ Roobol, EW Steyerberg, R Kranse et al. A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer Eur Urol 57 2010 79 85
    • (2010) Eur Urol , vol.57 , pp. 79-85
    • Roobol, M.J.1    Steyerberg, E.W.2    Kranse, R.3
  • 8
    • 79952282240 scopus 로고    scopus 로고
    • Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: Recommendations from a European consensus meeting
    • L Dickinson, HU Ahmed, C Allen et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting Eur Urol 59 2011 477 494
    • (2011) Eur Urol , vol.59 , pp. 477-494
    • Dickinson, L.1    Ahmed, H.U.2    Allen, C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.